(Q40189253)

English

An HPLC/mass spectrometry platform for the development of multimodality contrast agents and targeted therapeutics: prostate-specific membrane antigen small molecule derivatives

scientific article published on September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

An HPLC/mass spectrometry platform for the development of multimodality contrast agents and targeted therapeutics: prostate-specific membrane antigen small molecule derivatives (English)

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

1 reference

based on heuristic

inferred from title

John V Frangioni

3

object named as

John V Frangioni

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

author name string

Valerie Humblet

1

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

Preeti Misra

2

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

publication date

1 September 2006

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

Contrast Media & Molecular Imaging

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

1

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

5

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

196-211

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

22 September 2017

Cancer statistics, 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

22 September 2017

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

22 September 2017

An operational near-infrared fluorescence imaging system prototype for large animal surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

22 September 2017

The basics of mass spectrometry in the twenty-first century

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

22 September 2017

Tumor therapy with targeted atomic nanogenerators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

22 September 2017

NHS-MAS3: a bifunctional chelator alternative to NHS-MAG3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

22 September 2017

An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

25 September 2017

Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

25 September 2017

A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

20 August 2018

Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

20 August 2018

Prostate-specific membrane antigen directed selective thrombotic infarction of tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

20 August 2018

Phosphinic acid pseudopeptides analogous to glutamyl-gamma-glutamate: synthesis and coupling to pteroyl azides leads to potent inhibitors of folylpoly-gamma-glutamate synthetase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2734331

20 August 2018

Quantitation of brown adipose tissue perfusion in transgenic mice using near-infrared fluorescence imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/17193697

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17193697

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CMMI.106

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40189253&oldid=1888511262"